Tukey’s post hoc tests indicated that the number of GFAP positive glial cells in the prefrontal cortex were significantly increased in the 3 × Tg-AD control group compared to that of the non-Tg control group (p < 0.001; Figure 3E). This evidence concerns the gene GFAP and Alzheimer disease.